AC Immune Therapy chosen for groundbreaking Alzheimer's Disease Trial in Colombia and USA
16.May 2012 08:00 CET
- World's first Alzheimer's disease prevention trial before onset of symptoms in highest-risk individuals
- Trial funded by National Institutes of Health, Banner Alzheimer's Institute and Genentech
- Antibody discovered by AC Immune and exclusively licensed to Genentech